MedTrace Logo

The Effects of Caffeine Withdrawal on Migraine

NCT03022838 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-07-23

No results posted yet for this study

Summary

Sporadic and chronic dietary consumption of caffeine has substantial biological effects on the nervous system. The effects on migraine are at large not known. In this study we want to assess the effects of caffeine withdrawal on migraine.

Conditions

Interventions

DRUG

Caffeine

From the point of enrollment, patients will substitute their daily dietary caffeine with either placebo- or capsulated caffeine tablets (Recip®, 100mg).

Sponsors & Collaborators

  • King's College London

    collaborator OTHER

  • University Hospital of North Norway

    collaborator OTHER

  • Nordlandssykehuset HF

    lead OTHER

Principal Investigators

  • Jan T Henriksen · Department for research and patient safety, Nordland Hospital trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-28
Primary Completion
2019-07-22
Completion
2019-07-22

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03022838 on ClinicalTrials.gov